Promising Level C · preliminary human evidence
NAD+
Cellular energy
NAD+ biochemistry is well described. Its decline with age, and the effect of restoring it, are studied mostly in the laboratory and in animals.
Longevity Explorer
These are compounds from the scientific literature. They are not a sales catalog. None is presented as a way to live longer.
Promising Level C · preliminary human evidence
Cellular energy
NAD+ biochemistry is well described. Its decline with age, and the effect of restoring it, are studied mostly in the laboratory and in animals.
Promising Level C · preliminary human evidence
NAD+ precursor
Trials in adults have observed increases in blood NAD+ and acceptable short-term tolerability.
Early research Level C · preliminary human evidence
NAD+ precursor
Small human studies explore metabolism and insulin sensitivity. The body of evidence is still preliminary.
Early research Level C · preliminary human evidence
Polyphenols
The early expectation was larger than the later clinical evidence.
Promising Level B · moderate human evidence
Mitochondria
It is studied in deficiency and in some cardiac contexts. It is not a synonym for longevity.
Established Level A · strong human evidence
Nutrition
There is broad human evidence on triglycerides and cardiovascular health in defined contexts. That is not a label for living longer.
Early research Level C · preliminary human evidence
Autophagy
There are laboratory data, observations in populations, and human trials that are still small.
Established Level A · strong human evidence
Muscle
The performance evidence is broad. Interest in the brain and in aging is more recent and less conclusive.
Established Level A · strong human evidence
Foundational nutrition
Correcting a deficit makes nutritional sense. Supplementing without a deficit is not an anti-aging strategy.